DIFFERENT SUSCEPTIBILITY OF SMALL AND LARGE HUMAN TENASCIN-C ISOFORMS TO DEGRADATION BY MATRIX METALLOPROTEINASES

被引:150
作者
SIRI, A
KNAUPER, V
VEIRANA, N
CAOCCI, F
MURPHY, G
ZARDI, L
机构
[1] IST NAZL RIC CANC, CELL BIOL LAB, I-16132 GENOA, ITALY
[2] STRANGEWAYS RES LAB, CAMBRIDGE CB1 4RN, ENGLAND
基金
英国惠康基金;
关键词
D O I
10.1074/jbc.270.15.8650
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two major tenascin-C (TN-C) isoforms are generated by the alternative splicing of the pre-mRNA. The large isoform contains seven extra type three repeats that, by contrast, are omitted in the small TN-C isoform, The large TN-C isoform is mainly expressed at the onset of cellular processes that entail active cell migration, proliferation, or tissue remodeling such as occur in neoplasia, wound healing, and during development. Thus, the large TN-C isoform seems to be a specific component of the provisional extracellular matrix. Here we have studied the degradation of the large and small TN-C isoforms by matrix metalloproteinases (MMPs) 2, 3, 7, and 9. Among these proteolytic enzymes only MMP-7 can degrade the small TN-C isoform removing the NH2-terminal knob. The large TN-C isoform shows the same MMP-7-sensitive site adjacent to the NH2-terminal sequence, but is further degraded in the splicing area where three fibronectin-like type III repeats are completely digested. Moreover, the large TN-C isoform is degraded by MMP-2 and MMP-3 which completely digest a single type III repeat inside the splicing area. By contrast, the large TN-C isoform is resistant to MMP-9 digestion. The results show that the presence of the spliced sequence introduces new protease-sensitive sites in the large TN-C isoform.
引用
收藏
页码:8650 / 8654
页数:5
相关论文
共 49 条
  • [1] AUKHIL I, 1993, J BIOL CHEM, V268, P2542
  • [2] PRODUCTION AND CHARACTERIZATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR DIFFERENT EPITOPES OF HUMAN TENASCIN
    BALZA, E
    SIRI, A
    PONASSI, M
    CAOCCI, F
    LINNALA, A
    VIRTANEN, I
    ZARDI, L
    [J]. FEBS LETTERS, 1993, 332 (1-2) : 39 - 43
  • [3] CELL-CYCLE DEPENDENT ALTERNATIVE SPLICING OF THE TENASCIN PRIMARY TRANSCRIPT
    BORSI, L
    BALZA, E
    CASTELLANI, P
    CARNEMOLLA, B
    PONASSI, M
    QUERZE, G
    ZARDI, L
    [J]. CELL ADHESION AND COMMUNICATION, 1994, 1 (04) : 307 - 317
  • [4] EXPRESSION OF DIFFERENT TENASCIN ISOFORMS IN NORMAL, HYPERPLASTIC AND NEOPLASTIC HUMAN BREAST TISSUES
    BORSI, L
    CARNEMOLLA, B
    NICOLO, G
    SPINA, B
    TANARA, G
    ZARDI, L
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1992, 52 (05) : 688 - 692
  • [5] COMPARISON OF HUMAN TENASCIN EXPRESSION IN NORMAL, SIMIAN-VIRUS-40-TRANSFORMED AND TUMOR-DERIVED CELL-LINES
    CARNEMOLLA, B
    BORSI, L
    BANNIKOV, G
    TROYANOVSKY, S
    ZARDI, L
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 205 (02): : 561 - 567
  • [6] A TUMOR-ASSOCIATED FIBRONECTIN ISOFORM GENERATED BY ALTERNATIVE SPLICING OF MESSENGER-RNA PRECURSORS
    CARNEMOLLA, B
    BALZA, E
    SIRI, A
    ZARDI, L
    NICOTRA, MR
    BIGOTTI, A
    NATALI, PG
    [J]. JOURNAL OF CELL BIOLOGY, 1989, 108 (03) : 1139 - 1148
  • [7] ISOLATION OF CHICK TENASCIN VARIANTS AND FRAGMENTS - A C-TERMINAL HEPARIN-BINDING FRAGMENT PRODUCED BY CLEAVAGE OF THE EXTRA DOMAIN FROM THE LARGEST SUBUNIT SPLICING VARIANT
    CHIQUET, M
    VRUCINICFILIPI, N
    SCHENK, S
    BECK, K
    CHIQUETEHRISMANN, R
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 199 (02): : 379 - 388
  • [8] TENASCIN VARIANTS - DIFFERENTIAL BINDING TO FIBRONECTIN AND DISTINCT DISTRIBUTION IN CELL-CULTURES AND TISSUES
    CHIQUETEHRISMANN, R
    MATSUOKA, Y
    HOFER, U
    SPRING, J
    BERNASCONI, C
    CHIQUET, M
    [J]. CELL REGULATION, 1991, 2 (11): : 927 - 938
  • [9] CHIQUETEHRISMANN R, 1993, SEMIN CANCER BIOL, V4, P301
  • [10] CELL-SURFACE ANNEXIN-II IS A HIGH-AFFINITY RECEPTOR FOR THE ALTERNATIVELY SPLICED SEGMENT OF TENASCIN-C
    CHUNG, CY
    ERICKSON, HP
    [J]. JOURNAL OF CELL BIOLOGY, 1994, 126 (02) : 539 - 548